双重二酰甘油激酶(DGK)α/ζ 抑制剂在体内和离体模型中增强人 TIL(肿瘤浸润淋巴细胞)的活性 A dual diacylglycerol kinase (DGK) alpha/zeta inhibitor augments the activity of human tumor infiltrating lymphocytes in in vivo and ex vivo models. PubMed 2025/12/29 发表OncoimmunologyQ1 · IF 6.2(JCR 2025) 靶点:EGFR技术:TIL技术:双特异性抗体非小细胞肺癌头颈部肿瘤地区:美国